Market research
AXNA.F Amplifon S.p.A
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 3B
- P/E ratio
- 36.21
- Analyst target
- Not available
- Dividend yield
- 2.6%
- Beta
- 0.99
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Distribution
- ISIN
- IT0004056880
- Market cap
- 3B
- P/E ratio
- 36.21
- Analyst target
- Not available
- Dividend yield
- 2.6%
- Beta
- 0.99
About
About Amplifon S.p.A
Amplifon S.p.A. distributes hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. It operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. The company also offers Ampli-power and Ampli-mini hearing devices. Amplifon S.p.A. was founded in 1950 and is headquartered in Milan, Italy.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the AXNA.F discussion.
5 years, 5 months ago
Amplifon S.p.A is currently in a long term uptrend where the price is trading 17.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
Amplifon S.p.A's total revenue rose by 1.2% to $513M since the same quarter in the previous year.
Its net income has increased by 27.4% to $60M since the same quarter in the previous year.
Finally, its free cash flow grew by 197.3% to $151M since the same quarter in the previous year.
Based on the above factors, Amplifon S.p.A gets an overall score of 5/5.